Skip to main content
. 2019 Mar 27;19:286. doi: 10.1186/s12879-019-3919-1

Fig. 2.

Fig. 2

Number of drug resistant tuberculosis patients on second line anti-TB drugs stratified by TICs and major adverse drug events (ADEs) in Amhara Regional State Public hospitals, September 2010–December 2017